Vigil Neuroscience Launches with $50 Million in Financing to Develop Microglia-based Therapeutics for Neurodegenerative Diseases
Amount Raised
$50 Million
Round Type
Funding Round
CambridgeOtherBiotechnologyHealthcareDescription
Vigil Neuroscience, a new biotechnology company harnessing the power of microglia for the treatment of neurodegenerative diseases, launched today with $50 million Series A financing. Atlas Venture co-founded, seeded and incubated Vigil with late pre-clinical-stage assets in-licensed from Amgen Inc., who will remain a key shareholder in the company. The Series A round was co-led by Atlas Venture and Northpond Ventures and includes participating investors Hatteras Venture Partners and Alexandria Venture Investments. The company is led by industry veteran Ivana Magovčević-Liebisch, PhD, JD as President and Chief Executive Officer.
Quick answer
Vigil Neuroscience raised $50 Million in a Funding Round round, dated December 8, 2020. Vigil Neuroscience is based in Cambridge, Massachusetts, United States.
- How much did Vigil Neuroscience raise?
- Vigil Neuroscience raised $50 Million in a Funding Round round on December 8, 2020.
- What does Vigil Neuroscience do?
- Vigil Neuroscience is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain’s immune system.
- Where is Vigil Neuroscience based and how big is it?
- Vigil Neuroscience is based in Cambridge, Massachusetts, United States.
- Who are the decision-makers at Vigil Neuroscience?
- Fundz holds 1 contact at Vigil Neuroscience. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Vigil Neuroscience that raised within 45 days of this round, from Fundz verified event records.
- Lakewood-Amedex, Inc. raised $24M on January 22, 2021.
- Nocion Therapeutics raised $15M on January 22, 2021.
- Turn Medical, LLC raised $500K (Seed) on January 22, 2021.
- Optimvia raised $523K on January 20, 2021.
- Myra Vision raised $5.3M on January 20, 2021.
- Enveric Biosciences raised $13M on January 20, 2021.
Who to call at Vigil Neuroscience, and when
A new round usually means Vigil Neuroscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vigil Neuroscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vigil Neuroscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vigil Neuroscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vigil Neuroscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Vigil Neuroscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.